Calcium in PDB 3f18: Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide
Protein crystallography data
The structure of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide, PDB code: 3f18
was solved by
V.Calderone,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
30.16 /
1.13
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
51.709,
60.326,
53.992,
90.00,
115.07,
90.00
|
R / Rfree (%)
|
16.6 /
18.7
|
Other elements in 3f18:
The structure of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide
(pdb code 3f18). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 3 binding sites of Calcium where determined in the
Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide, PDB code: 3f18:
Jump to Calcium binding site number:
1;
2;
3;
Calcium binding site 1 out
of 3 in 3f18
Go back to
Calcium Binding Sites List in 3f18
Calcium binding site 1 out
of 3 in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca266
b:12.8
occ:1.00
|
O
|
A:HOH335
|
2.3
|
17.7
|
1.0
|
O
|
A:GLY192
|
2.3
|
7.5
|
1.0
|
O
|
A:GLY190
|
2.5
|
13.4
|
1.0
|
O
|
A:ASP158
|
2.5
|
7.6
|
1.0
|
O
|
A:HOH8
|
2.5
|
8.4
|
1.0
|
OD2
|
A:ASP194
|
2.6
|
8.1
|
1.0
|
O
|
A:HOH294
|
3.5
|
23.2
|
1.0
|
C
|
A:GLY192
|
3.5
|
7.2
|
1.0
|
CG
|
A:ASP194
|
3.5
|
7.3
|
1.0
|
C
|
A:ASP158
|
3.5
|
6.6
|
1.0
|
C
|
A:GLY190
|
3.6
|
12.5
|
1.0
|
C
|
A:ILE191
|
3.8
|
10.3
|
1.0
|
OD1
|
A:ASP194
|
3.9
|
8.2
|
1.0
|
O
|
A:ALA157
|
3.9
|
9.5
|
1.0
|
N
|
A:GLY192
|
3.9
|
9.2
|
1.0
|
O
|
A:ILE191
|
4.0
|
9.7
|
1.0
|
CA
|
A:ILE191
|
4.1
|
11.7
|
1.0
|
CA
|
A:GLY192
|
4.3
|
8.3
|
1.0
|
N
|
A:ASP194
|
4.3
|
5.9
|
1.0
|
N
|
A:ILE191
|
4.3
|
12.0
|
1.0
|
O
|
A:HOH45
|
4.3
|
14.5
|
1.0
|
CA
|
A:ASP158
|
4.3
|
7.1
|
1.0
|
N
|
A:ILE159
|
4.4
|
6.2
|
1.0
|
N
|
A:GLY193
|
4.5
|
6.7
|
1.0
|
O
|
A:GLY188
|
4.5
|
11.0
|
1.0
|
O
|
A:HOH304
|
4.5
|
29.3
|
1.0
|
CA
|
A:ILE159
|
4.6
|
6.1
|
1.0
|
CA
|
A:GLY193
|
4.6
|
6.5
|
1.0
|
N
|
A:LEU160
|
4.7
|
6.3
|
1.0
|
C
|
A:GLY193
|
4.7
|
6.1
|
1.0
|
CA
|
A:GLY190
|
4.7
|
12.8
|
1.0
|
CB
|
A:ASP194
|
4.7
|
6.5
|
1.0
|
N
|
A:GLY190
|
4.8
|
12.7
|
1.0
|
O
|
A:HOH26
|
4.9
|
10.2
|
1.0
|
CA
|
A:ASP194
|
4.9
|
6.3
|
1.0
|
C
|
A:ALA157
|
4.9
|
8.8
|
1.0
|
C
|
A:SER189
|
5.0
|
12.6
|
1.0
|
|
Calcium binding site 2 out
of 3 in 3f18
Go back to
Calcium Binding Sites List in 3f18
Calcium binding site 2 out
of 3 in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca267
b:6.1
occ:1.00
|
O
|
A:GLU199
|
2.3
|
6.6
|
1.0
|
O
|
A:HOH11
|
2.4
|
8.1
|
1.0
|
O
|
A:HOH20
|
2.4
|
7.6
|
1.0
|
OE2
|
A:GLU199
|
2.4
|
6.5
|
1.0
|
OD2
|
A:ASP124
|
2.4
|
5.9
|
1.0
|
O
|
A:GLU201
|
2.4
|
6.6
|
1.0
|
OD1
|
A:ASP124
|
2.6
|
6.5
|
1.0
|
CG
|
A:ASP124
|
2.8
|
5.6
|
1.0
|
C
|
A:GLU199
|
3.4
|
6.4
|
1.0
|
CD
|
A:GLU199
|
3.4
|
6.7
|
1.0
|
C
|
A:GLU201
|
3.6
|
6.5
|
1.0
|
CG
|
A:GLU199
|
3.8
|
6.7
|
1.0
|
CA
|
A:GLU199
|
4.1
|
6.3
|
1.0
|
OG1
|
A:THR122
|
4.1
|
6.0
|
1.0
|
CA
|
A:PHE202
|
4.2
|
7.0
|
1.0
|
CB
|
A:ASP124
|
4.3
|
5.9
|
1.0
|
N
|
A:PHE202
|
4.4
|
6.9
|
1.0
|
N
|
A:GLU201
|
4.4
|
6.7
|
1.0
|
CD1
|
A:TRP203
|
4.4
|
5.7
|
1.0
|
N
|
A:ASP200
|
4.5
|
6.7
|
1.0
|
C
|
A:ASP200
|
4.5
|
7.1
|
1.0
|
OE1
|
A:GLU199
|
4.6
|
7.2
|
1.0
|
CB
|
A:GLU199
|
4.6
|
6.4
|
1.0
|
CA
|
A:ASP200
|
4.7
|
7.1
|
1.0
|
NH2
|
A:ARG165
|
4.7
|
11.0
|
1.0
|
CA
|
A:GLU201
|
4.7
|
6.8
|
1.0
|
O
|
A:HOH13
|
4.8
|
9.4
|
1.0
|
CD1
|
A:PHE202
|
4.8
|
8.8
|
1.0
|
N
|
A:TRP203
|
4.9
|
6.4
|
1.0
|
NE1
|
A:TRP203
|
4.9
|
6.1
|
1.0
|
|
Calcium binding site 3 out
of 3 in 3f18
Go back to
Calcium Binding Sites List in 3f18
Calcium binding site 3 out
of 3 in the Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of the Catalytic Domain of Human MMP12 Complexed with the Inhibitor 4-Fluoro-N-(2-Hydroxyethyl)-N- (2-Nitroso-2-Oxoethyl)Benzenesulfonamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca268
b:9.7
occ:1.00
|
OE2
|
A:GLU201
|
2.2
|
12.5
|
1.0
|
O
|
A:GLY176
|
2.3
|
9.9
|
1.0
|
O
|
A:ILE180
|
2.3
|
10.1
|
1.0
|
OD2
|
A:ASP175
|
2.3
|
9.3
|
1.0
|
OD1
|
A:ASP198
|
2.3
|
8.4
|
1.0
|
O
|
A:GLY178
|
2.4
|
11.0
|
1.0
|
C
|
A:ILE180
|
3.4
|
9.5
|
1.0
|
CD
|
A:GLU201
|
3.4
|
10.3
|
1.0
|
CG
|
A:ASP198
|
3.4
|
6.9
|
1.0
|
CG
|
A:ASP175
|
3.5
|
9.7
|
1.0
|
C
|
A:GLY176
|
3.5
|
9.9
|
1.0
|
C
|
A:GLY178
|
3.6
|
11.2
|
1.0
|
N
|
A:GLY178
|
3.9
|
11.3
|
1.0
|
N
|
A:ILE180
|
3.9
|
10.5
|
1.0
|
CB
|
A:ASP198
|
4.0
|
6.5
|
1.0
|
OD1
|
A:ASP175
|
4.1
|
11.2
|
1.0
|
N
|
A:GLY176
|
4.1
|
9.6
|
1.0
|
OE1
|
A:GLU201
|
4.1
|
10.4
|
1.0
|
C
|
A:LYS177
|
4.2
|
11.1
|
1.0
|
CA
|
A:ILE180
|
4.2
|
10.3
|
1.0
|
N
|
A:ASP175
|
4.2
|
9.0
|
1.0
|
C
|
A:ASP175
|
4.3
|
9.6
|
1.0
|
C
|
A:GLY179
|
4.3
|
10.8
|
1.0
|
CA
|
A:GLY178
|
4.3
|
11.4
|
1.0
|
OD2
|
A:ASP198
|
4.4
|
6.8
|
1.0
|
N
|
A:LYS177
|
4.4
|
10.3
|
1.0
|
CA
|
A:GLY176
|
4.4
|
9.7
|
1.0
|
N
|
A:LEU181
|
4.4
|
8.3
|
1.0
|
CA
|
A:LYS177
|
4.4
|
10.9
|
1.0
|
CG
|
A:GLU201
|
4.5
|
8.2
|
1.0
|
N
|
A:GLY179
|
4.6
|
11.3
|
1.0
|
CA
|
A:ASP175
|
4.6
|
9.6
|
1.0
|
CB
|
A:ASP175
|
4.6
|
9.8
|
1.0
|
CA
|
A:LEU181
|
4.6
|
7.9
|
1.0
|
CB
|
A:ILE180
|
4.6
|
10.6
|
1.0
|
O
|
A:ASP175
|
4.7
|
10.0
|
1.0
|
CA
|
A:GLY179
|
4.7
|
11.0
|
1.0
|
O
|
A:LYS177
|
4.7
|
11.5
|
1.0
|
O
|
A:GLY179
|
4.8
|
11.5
|
1.0
|
|
Reference:
I.Bertini,
V.Calderone,
M.Fragai,
A.Giachetti,
M.Loconte,
C.Luchinat,
M.Maletta,
C.Nativi,
K.J.Yeo.
Exploring the Subtleties of Drug-Receptor Interactions: the Case of Matrix Metalloproteinases. J.Am.Chem.Soc. V. 129 2466 2007.
ISSN: ISSN 0002-7863
PubMed: 17269766
DOI: 10.1021/JA065156Z
Page generated: Sat Jul 13 09:40:08 2024
|